User profiles for Ahmad Separham

ahmad separham

Professor of interventional cardiology, Tabriz university of medical science
Verified email at tbzmed.ac.ir
Cited by 677

Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF‐κB, and MCP‐1 in patients with coronary artery disease: A …

…, S Abedimanesh, SZ Bathaie, A Separham… - Phytotherapy …, 2020 - Wiley Online Library
This trial evaluated the potential impacts of saffron aqueous extract (SAE) and its main
carotenoid on some of the atherosclerosis‐related gene expression and serum levels of oxidized …

Effects of betalains on atherogenic risk factors in patients with atherosclerotic cardiovascular disease

…, A Ostadrahimi, S Abedimanesh, A Separham… - Food & function, 2019 - pubs.rsc.org
This study evaluated the potential impacts of supplementation with betalain-rich extracts of
foods on some atherosclerotic risk factors in coronary artery disease patients. During an …

[HTML][HTML] Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease

…, S Abedimanesh, B Motlagh, A Separham… - … of cardiovascular and …, 2017 - ncbi.nlm.nih.gov
Introduction: Central obesity is an independent risk factor for coronary artery disease (CAD).
It can increase cardio-metabolic risks through hypertension, hyperlipidemia and insulin …

Clinical and laboratory predictors of coronary slow flow in coronary angiography

S Ghaffari, A Tajlil, N Aslanabadi, A Separham… - …, 2017 - journals.sagepub.com
Background: The coronary slow-flow phenomenon (CSFP) is a multifactorial angiographic
finding with no established pathogenesis. Objective: To investigate the role of clinical profile …

[HTML][HTML] Association of neutrophil to lymphocyte ratio (NLR) with angiographic SYNTAX score in patients with non-ST-Segment elevation acute coronary syndrome …

M Maleki, A Tajlil, A Separham, B Sohrabi… - … of Cardiovascular and …, 2021 - ncbi.nlm.nih.gov
Introduction: Considering the role of inflammation in pathogenesis of atherosclerosis, we
aimed to investigate the association of presentation neutrophil to lymphocyte ratio (NLR) with …

Betalain-and betacyanin-rich supplements' impacts on the PBMC SIRT1 and LOX1 genes expression and Sirtuin-1 protein levels in coronary artery disease patients: A …

…, SA Mesbah-Namin, A Ostadrahimi, A Separham… - Journal of functional …, 2019 - Elsevier
Activation of Sirtuin-1 (SIRT1) is a considered candidate for the prevention of cardiovascular
diseases. SIRT1 as a longevity factor regulates human cell lifespan and influences aspects …

[HTML][HTML] Prognostic value of platelet indices in patients with acute pulmonary thromboembolism

…, N Parvizian, L Pourafkari, A Separham… - … of cardiovascular and …, 2020 - ncbi.nlm.nih.gov
Introduction: Given the role of platelets in thrombus formation, markers of platelet activation
may be able to predict outcomes in patients with acute pulmonary thromboembolism (PTE). …

A novel inflammatory signaling pathway in patients with slow coronary flow: NF-κB/IL-1β/nitric oxide

…, NM Alamdari, A Ostadrahimi, A Separham… - Cytokine, 2021 - Elsevier
Purpose The slow coronary flow (SCF) was identified as delayed opacification of epicardial
coronary arteries in the absence of stenotic lesion. Metabolic syndrome (MetS), oxidative …

[HTML][HTML] Difference between outcome of left circumflex artery and right coronary artery related acute inferior wall myocardial infarction in patients undergoing …

B Sohrabi, A Separham, R Madadi… - … of cardiovascular and …, 2014 - ncbi.nlm.nih.gov
Introduction: Prognostic differences between anterior and inferior wall Myocardial Infarction (MI)
has been extensively investigated, but there is limited information about similar …

The impact of allopurinol on patients with acute ST elevation myocardial infarction undergoing thrombolytic therapy

A Separham, S Ghaffari, H Najafi… - Journal of …, 2016 - journals.lww.com
Allopurinol may have protective effects over ischemic reperfusion injury and reduce infarct
size. In this randomized study, we aimed to evaluate the impact of allopurinol in patients with …